Breast Cancer - Anti-Progestin Prevention Study 1

Summary

The primary objective of this study is to determine the effects of the antiprogestin ulipristal acetate (UA) on the epithelial and stromal compartments of the normal breast in women at increased risk of breast cancer (BC) and to relate these effects to quantitative changes on multiparametric magnetic resonance imaging (MRI). The goal is to define predictive imaging biomarkers for subsequent testing in randomised prevention trials of antiprogestins.

Timeline

Start

2016-01-22

Primary completion

2019-03-18

Completion

2023-01-25

Drugs

Indications